laboratory report - hillsborough county, florida€¦ · 18/06/2018 · laboratory report this...

LABORATORY REPORT

This report may not be reproduced, except in full, without written approval from EEA.

If you have any questions concerning this report, please do not hesitate to call us at (800) 332-4345 or (574) 233-4777.

of 13

Revision date: 01/02/2018

STATE CERTIFICATION LIST

State Certification State Certification Alabama 40700 Missouri 880 Alaska IN00035 Montana CERT0026 Arizona AZ0432 Nebraska NE-OS-05-04

Arkansas IN00035 Nevada IN00035 California 2920 New Hampshire* 2124 Colorado IN035 New Jersey* IN598

Colorado Radiochemistry IN035 New Mexico IN00035 Connecticut PH-0132 New York* 11398 Delaware IN035 North Carolina 18700 Florida* E87775 North Dakota R-035 Georgia 929 Ohio 87775 Hawaii IN035 Oklahoma D9508 Idaho IN00035 Oregon (Primary AB)* 4074-001

Illinois* 200001 Pennsylvania* 68-00466 Illinois Microbiology 17767 Puerto Rico IN00035

Illinois Radiochemistry IN00035 Rhode Island LAO00343 Indiana Chemistry C-71-01 South Carolina 95005

Indiana Microbiology M-76-07 South Dakota IN00035 Iowa 098 Tennessee TN02973

Kansas* E-10233 Texas* T104704187-15-8Kentucky 90056 Texas/TCEQ TX207

Louisiana* LA180008 Utah* IN00035 Maine IN00035 Vermont VT-8775

Maryland 209 Virginia* 460275 Massachusetts M-IN035 Washington C837

Michigan 9926 West Virginia 9927 C Minnesota* 018-999-338 Wisconsin 999766900 Mississippi IN035 Wyoming IN035

EPA IN00035 *NELAP/TNI Recognized Accreditation Bodies

of 13

Laboratory Report

Client:

Attn:

Report:

Priority:

Status:

PWS ID:

Hillsborough County Board of County Commissioners

Ed Watson

332 N. Falkenburd Rd.

419634

FL6290787

Standard Written

Final

Tampa, FL 33619

Sample Event Code:

PWS Facility ID:

Sampling Point ID:

00002

0787002

SE4

Lab ID Code: IN00035

110 South Hill StreetSouth Bend, IN 46617Tel: (574) 233-4777Fax: (574) 233-82071 800 332 4345

EEA ID #

Client ID Method CollectedDate / Time

CollectedBy:

ReceivedDate / Time

3964282 0787002 Central 545 06/18/18 12:02 Client 06/19/18 09:30

3964283 0787002 Central 546 06/18/18 12:02 Client 06/19/18 09:30

Sample Information

Report Summary

Detailed quantitative results are presented on the following pages. The results presented relate only to the samples provided for analysis.

We appreciate the opportunity to provide you with this analysis. If you have any questions concerning this report, please do not hesitate to call Jessie Brasch at (574) 233-4777.

Note: This report may not be reproduced, except in full, without written approval from EEA.

Client Name:

Report #:


419634

Authorized Signature Title Date

09/09/2018

Page 1 of 2

of 13

Client Name: Report #: 419634Hillsborough County Board of County Commissioners

Sampling Point ID: PWS ID: FL62907870787002

UCMR Result Summary

AnalyteID #

Analyte Method MRL† Result Units PreparationDate

AnalyzedDate

EEAID #

3311 Anatoxin-a 545 0.0300 < 0.0300 ug/L 06/20/18 13:14 06/20/18 21:12 3964282

3302 Cylindrospermopsin 545 0.0900 < 0.0900 ug/L 06/20/18 13:14 06/20/18 21:12 3964282

3301 Total Microcystins & Nodularins 546 0.300 < 0.300 ug/L 06/25/18 14:00 06/26/18 08:19 3964283

CVTM Percent CV 546 N/A 8.00 % 06/25/18 14:00 06/26/18 08:19 3964283

† EEA has demonstrated it can achieve these report limits in reagent water, but can not document them in all sample matrices.

Page 2 of 2

of 13

Lab Definitions

Continuing Calibration Check Standard (CCC) / Continuing Calibration Verification (CCV) / Initial Calibration Verification Standard (ICV) / Initial Performance Check (IPC) - is a standard containing one or more of the target analytes that is prepared from the same standards used to calibrate the instrument. This standard is used to verify the calibration curve at the beginning of each analytical sequence, and may also be analyzed throughout and at the end of the sequence. The concentration of continuing standards may be varied, when prescribed by the reference method, so that the range of the calibration curve is verified on a regular basis. CCL, CCM, and CCH are the CCC standards at low, mid, and high concentration levels, respectively.

Internal Standards (IS) - are pure compounds with properties similar to the analytes of interest, which are added to field samples or extracts, calibration standards, and quality control standards at a known concentration. They are used to measure the relative responses of the analytes of interest and surrogates in the sample, calibration standard or quality control standard.

Laboratory Duplicate (LD) - is a field sample aliquot taken from the same sample container in the laboratory and analyzed separately using identical procedures. Analysis of laboratory duplicates provides a measure of the precision of the laboratory procedures.

Laboratory Fortified Blank (LFB) / Laboratory Control Sample (LCS) - is an aliquot of reagent water to which known concentrations of the analytes of interest are added. The LFB is analyzed exactly the same as the field samples. LFBs are used to determine whether the method is in control. FBL, FBM, and FBH are the LFB samples at low, mid, and high concentration levels, respectively.

Laboratory Method Blank (LMB) / Laboratory Reagent Blank (LRB) - is a sample of reagent water included in the sample batch analyzed in the same way as the associated field samples. The LMB is used to determine if method analytes or other background contamination have been introduced during the preparation or analytical procedure. The LMB is analyzed exactly the same as the field samples.

Laboratory Trip Blank (LTB) / Field Reagent Blank (FRB) - is a sample of laboratory reagent water placed in a sample container in the laboratory and treated as a field sample, including storage, preservation, and all analytical procedures. The FRB/LTB container follows the collection bottles to and from the collection site, but the FRB/LTB is not opened at any time during the trip. The FRB/LTB is primarily a travel blank used to verify that the samples were not contaminated during shipment.

Matrix Spike Duplicate Sample (MSD) / Laboratory Fortified Sample Matrix Duplicate (LFSMD) - is a sample aliquot taken from the same field sample source as the Matrix Spike Sample to which known quantities of the analytes of interest are added in the laboratory. The MSD is analyzed exactly the same as the field samples. Analysis of the MSD provides a measure of the precision of the laboratory procedures in a specific matrix. SDL, SDM, and SDH / LFSMDL, LFSMDM, and LFSMDH are the MSD or LFSMD at low, mid, and high concentration levels, respectively.

Matrix Spike Sample (MS) / Laboratory Fortified Sample Matrix (LFSM) - is a sample aliquot taken from field sample source to which known quantities of the analytes of interest are added in the laboratory. The MS is analyzed exactly the same as the field samples. The purpose is to demonstrate recovery of the analytes from a sample matrix to determine if the specific matrix contributes bias to the analytical results. MSL, MSM, and MSH / LFSML, LFSMM, and LFSMH are the MS or LFSM at low, mid, and high concentration levels, respectively.

Quality Control Standard (QCS) / Second Source Calibration Verification (SSCV) - is a solution containing known concentrations of the analytes of interest prepared from a source different from the source of the calibration standards. The solution is obtained from a second manufacturer or lot if the lot can be demonstrated by the manufacturer as prepared independently from other lots. The QCS sample is analyzed using the same procedures as field samples. The QCS is used as a check on the calibration standards used in the method on a routine basis.

Reporting Limit Check (RLC) / Initial Calibration Check Standard (ICCS) - is a procedural standard that is analyzed each day to evaluate instrument performance at or below the minimum reporting limit (MRL).

Surrogate Standard (SS) / Surrogate Analyte (SUR) - is a pure compound with properties similar to the analytes of interest, which is highly unlikely to be found in any field sample, that is added to the field samples, calibration standards, blanks and quality control standards before sample preparation. The SS is used to evaluate the efficiency of the sample preparation process.

Page 1 of 1

of 13

Laboratory Report

Client:

Attn:

Report:

Priority:

Status:

PWS ID:


Ed Watson


419634

FL6290787

Standard Written

Final

Tampa, FL 33619


EEA ID #


CollectedBy:

ReceivedDate / Time

3964281 0787002 Central 544 06/18/18 12:02 Client 06/19/18 09:30

Sample Information

Report Summary

Method 544 analysis will be performed only if the associated Screening Microcystin by EPA 546 sample result is >=0.3 ug/L.




09/09/2018

Page 1 of 1

of 13

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:244911

Meth

od:

545

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L3

96

50

67

CY

06

20

18

M5

45

a-C

Y.m

db

06

/20

/20

18

19

:15

RW

QC

S3

96

50

68

CY

06

20

18

M5

45

a-C

Y.m

db

06

/20

/20

18

19

:29

RW

LR

B3

96

57

11C

Y0

62

01

8M

54

5a

-CY

.md

b0

6/2

0/2

01

8 1

9:4

4R

W

FS

39

64

28

20

78

70

02

Ce

ntr

al

CY

06

20

18

M5

45

a-C

Y.m

db

06

/20

/20

18

21

:12

DW

CC

M3

96

50

81

CY

06

20

18

M5

45

a-C

Y.m

db

06

/20

/20

18

22

:25

RW

0.0

0

Page 1

of

2E

EA

Run I

D 2

44911

/ E

EA

Report

# 4

19634

of 13

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

eco

ve

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

CC

L3

79

82

ug

/L1

.03

96

50

67

---

---

---

50

- 1

50

119

31

85

7

06

/20

/20

18

09

:50

06

/20

/20

18

19

:15

Fals

e

IS-U

raci

l-d4

545

N/A

CC

L5

27

3ug

/L1

.03

96

50

67

---

---

---

50

- 1

50

10

35

12

0

06

/20

/20

18

09

:50

06

/20

/20

18

19

:15

Fals

e

Anato

xin-a

545

0.0

300

CC

L0

.03

29

92

ug

/L1

.03

96

50

67

---

---

---

50

- 1

50

110

0.0

3

06

/20

/20

18

09

:50

06

/20

/20

18

19

:15

Fals

e

Cyl

indro

sperm

opsi

n545

0.0

900

CC

L0

.09

42

71

ug

/L1

.03

96

50

67

---

---

---

50

- 1

50

10

50

.09

0

6/2

0/2

01

8 0

9:5

00

6/2

0/2

01

8 1

9:1

5T

rue

IS-L

-phenyl

ala

nin

e-d

5545

N/A

QC

S3

03

71

ug

/L1

.03

96

50

68

---

---

---

50

- 1

50

95

31

85

7

06

/20

/20

18

09

:50

06

/20

/20

18

19

:29

Tru

e

IS-U

raci

l-d4

545

N/A

QC

S5

04

1ug

/L1

.03

96

50

68

---

---

---

50

- 1

50

98

51

20

0

6/2

0/2

01

8 0

9:5

00

6/2

0/2

01

8 1

9:2

9T

rue

Anato

xin-a

545

0.0

300

QC

S0

.56

29

44

ug

/L1

.03

96

50

68

---

---

---

70

- 1

30

113

0.5

0

6/2

0/2

01

8 0

9:5

00

6/2

0/2

01

8 1

9:2

9T

rue

Cyl

indro

sperm

opsi

n545

0.0

900

QC

S1

.61

98

8ug

/L1

.03

96

50

68

---

---

---

70

- 1

30

10

81

.5

06

/20

/20

18

09

:50

06

/20

/20

18

19

:29

Fals

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

LR

B2

88

93

ug

/L1

.03

96

57

11--

---

---

-5

0 -

15

09

13

18

57

0

6/2

0/2

01

8 1

3:1

40

6/2

0/2

01

8 1

9:4

4F

als

e

IS-U

raci

l-d4

545

N/A

LR

B5

88

2ug

/L1

.03

96

57

11--

---

---

-5

0 -

15

011

55

12

0

06

/20

/20

18

13

:14

06

/20

/20

18

19

:44

Fals

e

Anato

xin-a

545

0.0

300

LR

B0

.0ug

/L1

.03

96

57

11--

---

---

---

---

-

<0

6/2

0/2

01

8 1

3:1

40

6/2

0/2

01

8 1

9:4

4F

als

e

Cyl

indro

sperm

opsi

n545

0.0

900

LR

B0

.0ug

/L1

.03

96

57

11--

---

---

---

---

-

<0

6/2

0/2

01

8 1

3:1

40

6/2

0/2

01

8 1

9:4

4T

rue

IS-L

-phenyl

ala

nin

e-d

5545

N/A

FS

25

10

8ug

/L1

.03

96

42

82

07

87

00

2 C

entr

al

---

---

50

- 1

50

79

31

85

7

06

/20

/20

18

13

:14

06

/20

/20

18

21

:12

Tru

e

IS-U

raci

l-d4

545

N/A

FS

54

44

ug

/L1

.03

96

42

82

07

87

00

2 C

entr

al

---

---

50

- 1

50

10

65

12

0

06

/20

/20

18

13

:14

06

/20

/20

18

21

:12

Tru

e

Anato

xin-a

545

0.0

300

FS

0.0

30

0ug

/L1

.03

96

42

82

07

87

00

2 C

entr

al

---

---

---

---

<

06

/20

/20

18

13

:14

06

/20

/20

18

21

:12

Tru

e

Cyl

indro

sperm

opsi

n545

0.0

900

FS

0.0

90

0ug

/L1

.03

96

42

82

07

87

00

2 C

entr

al

---

---

---

---

<

06

/20

/20

18

13

:14

06

/20

/20

18

21

:12

Fals

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

CC

M2

52

50

ug

/L1

.03

96

50

81

---

---

---

50

- 1

50

79

31

85

7

06

/20

/20

18

09

:50

06

/20

/20

18

22

:25

Fals

e

IS-U

raci

l-d4

545

N/A

CC

M4

65

3ug

/L1

.03

96

50

81

---

---

---

50

- 1

50

91

51

20

0

6/2

0/2

01

8 0

9:5

00

6/2

0/2

01

8 2

2:2

5F

als

e

Anato

xin-a

545

0.0

300

CC

M0

.55

68

44

ug

/L1

.03

96

50

81

---

---

---

70

- 1

30

111

0.5

0

6/2

0/2

01

8 0

9:5

00

6/2

0/2

01

8 2

2:2

5F

als

e

Cyl

indro

sperm

opsi

n545

0.0

900

CC

M1

.45

72

8ug

/L1

.03

96

50

81

---

---

---

70

- 1

30

97

1.5

0

6/2

0/2

01

8 0

9:5

00

6/2

0/2

01

8 2

2:2

5

Page 2

of

2E

EA

Run I

D 2

44911

/ E

EA

Report

# 4

19634

of 13

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:245106

Meth

od:

546

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

FS

39

64

28

30

78

70

02

Ce

ntr

al

FH

06

/26

/20

18

08

:19

DW

LR

B3

97

211

6F

H0

6/2

6/2

01

8 0

8:1

9R

W

LR

B3

97

211

7F

H0

6/2

6/2

01

8 0

8:1

9R

W

LF

B3

97

21

20

FH

06

/26

/20

18

08

:19

RW

LF

B3

97

21

21

FH

06

/26

/20

18

08

:19

RW

CC

L3

97

21

23

FH

06

/26

/20

18

08

:19

RW

QC

S3

97

21

25

FH

06

/26

/20

18

08

:19

RW

FS

39

64

28

30

78

70

02

Ce

ntr

al

FH

06

/26

/20

18

08

:19

DW

LR

B3

97

211

6F

H0

6/2

6/2

01

8 0

8:1

9R

W

LR

B3

97

211

7F

H0

6/2

6/2

01

8 0

8:1

9R

W

0.0

0

Page 1

of

2E

EA

Run I

D 2

45106 /

EE

A R

eport

# 4

19634

of 13

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

eco

ve

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

FS

0.3

00

ug

/L1

.03

96

42

83

07

87

00

2 C

entr

al

---

---

---

---

<

06

/25

/20

18

14

:00

06

/26

/20

18

08

:19

Fals

e

Perc

ent C

V546

N/A

FS

8%

1.0

39

64

28

30

78

70

02

Ce

ntr

al

---

---

---

---

06

/25

/20

18

14

:00

06

/26

/20

18

08

:19

Tru

e

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

LR

B0

.01

4ug

/L1

.03

97

211

6--

---

---

---

---

-

<0

6/2

5/2

01

8 1

4:0

00

6/2

6/2

01

8 0

8:1

9T

rue

Perc

ent C

V546

N/A

LR

B0

.8%

1.0

39

72

116

---

---

---

---

---

06

/25

/20

18

14

:00

06

/26

/20

18

08

:19

Fals

e

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

LR

B0

.0ug

/L1

.03

97

211

7--

---

---

---

---

-

<0

6/2

5/2

01

8 1

4:0

00

6/2

6/2

01

8 0

8:1

9F

als

e

Perc

ent C

V546

N/A

LR

B2

.1%

1.0

39

72

117

---

---

---

---

---

06

/25

/20

18

14

:00

06

/26

/20

18

08

:19

Tru

e

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

LF

B0

.45

ug

/L1

.03

97

21

20

---

---

---

60

- 1

40

90

0.5

0

6/2

5/2

01

8 1

4:0

00

6/2

6/2

01

8 0

8:1

9F

als

e

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

LF

B0

.45

6ug

/L1

.03

97

21

21

---

---

---

60

- 1

40

91

0.5

0

6/2

5/2

01

8 1

4:0

00

6/2

6/2

01

8 0

8:1

9T

rue

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

CC

L0

.30

79

99

ug

/L1

.03

97

21

23

---

---

---

50

- 1

50

10

30

.3

---

06

/26

/20

18

08

:19

Fals

e

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

QC

S0

.60

19

99

ug

/L1

.03

97

21

25

---

---

---

70

- 1

30

10

00

.6

---

06

/26

/20

18

08

:19

Page 2

of

2E

EA

Run I

D 2

45106 /

EE

A R

eport

# 4

19634

of 13

Sa

mp

le T

yp

e K

ey

Typ

e (

Ab

br.

)S

am

ple

Typ

eTyp

e (

Ab

br.

)S

am

ple

Typ

e

CC

LC

ontin

uin

g C

alib

ratio

n L

ow

CC

MC

ontin

uin

g C

alib

ratio

n M

id

FS

Fie

ld S

am

ple

LF

BLabora

tory

Fort

ifie

d B

lank

LR

BLabora

tory

Reagent

Bla

nk

QC

SQ

ualit

y C

ontr

ol S

am

ple

1.0

0

of 13

END OF REPORT

of 13

LABORATORY REPORT

This report may not be reproduced, except in full, without written approval from EEA.

If you have any questions concerning this report, please do not hesitate to call us at (800) 332-4345 or (574) 233-4777.

Page 1 of 7

Revision date: 01/02/2018

STATE CERTIFICATION LIST

State Certification State Certification Alabama 40700 Missouri 880 Alaska IN00035 Montana CERT0026 Arizona AZ0432 Nebraska NE-OS-05-04

Arkansas IN00035 Nevada IN00035 California 2920 New Hampshire* 2124 Colorado IN035 New Jersey* IN598

Colorado Radiochemistry IN035 New Mexico IN00035 Connecticut PH-0132 New York* 11398 Delaware IN035 North Carolina 18700 Florida* E87775 North Dakota R-035 Georgia 929 Ohio 87775 Hawaii IN035 Oklahoma D9508 Idaho IN00035 Oregon (Primary AB)* 4074-001

Illinois* 200001 Pennsylvania* 68-00466 Illinois Microbiology 17767 Puerto Rico IN00035

Illinois Radiochemistry IN00035 Rhode Island LAO00343 Indiana Chemistry C-71-01 South Carolina 95005

Indiana Microbiology M-76-07 South Dakota IN00035 Iowa 098 Tennessee TN02973

Kansas* E-10233 Texas* T104704187-15-8Kentucky 90056 Texas/TCEQ TX207

Louisiana* LA180008 Utah* IN00035 Maine IN00035 Vermont VT-8775

Maryland 209 Virginia* 460275 Massachusetts M-IN035 Washington C837

Michigan 9926 West Virginia 9927 C Minnesota* 018-999-338 Wisconsin 999766900 Mississippi IN035 Wyoming IN035

EPA IN00035 *NELAP/TNI Recognized Accreditation Bodies

Page 2 of 7

Laboratory Report

Client:

Attn:

Report:

Priority:

Status:

PWS ID:


Ed Watson


419632

FL6290787

Standard Written

Final

Tampa, FL 33619

Sample Event Code:

PWS Facility ID:

Sampling Point ID:

00001

0787001

SE4

Lab ID Code: IN00035


EEA ID #


CollectedBy:

ReceivedDate / Time

3964279 0787001 Lithia 545 06/18/18 13:11 Client 06/19/18 09:30

3964280 0787001 Lithia 546 06/18/18 00:00 Client 06/19/18 09:30

Sample Information

Report Summary

Detailed quantitative results are presented on the following pages. The results presented relate only to the samples provided for analysis.



Client Name:

Report #:


419632


09/09/2018

Page 1 of 2

Page 3 of 7

Client Name: Report #: 419632Hillsborough County Board of County Commissioners

Sampling Point ID: PWS ID: FL62907870787001

UCMR Result Summary

AnalyteID #

Analyte Method MRL† Result Units PreparationDate

AnalyzedDate

EEAID #

3311 Anatoxin-a 545 0.0300 < 0.0300 ug/L 06/20/18 13:14 06/20/18 20:57 3964279

3302 Cylindrospermopsin 545 0.0900 < 0.0900 ug/L 06/20/18 13:14 06/20/18 20:57 3964279

3301 Total Microcystins & Nodularins 546 0.300 < 0.300 ug/L 06/25/18 14:00 06/26/18 08:19 3964280

CVTM Percent CV 546 N/A 0.400 % 06/25/18 14:00 06/26/18 08:19 3964280

† EEA has demonstrated it can achieve these report limits in reagent water, but can not document them in all sample matrices.

Page 2 of 2

Page 4 of 7

Lab Definitions

Continuing Calibration Check Standard (CCC) / Continuing Calibration Verification (CCV) / Initial Calibration Verification Standard (ICV) / Initial Performance Check (IPC) - is a standard containing one or more of the target analytes that is prepared from the same standards used to calibrate the instrument. This standard is used to verify the calibration curve at the beginning of each analytical sequence, and may also be analyzed throughout and at the end of the sequence. The concentration of continuing standards may be varied, when prescribed by the reference method, so that the range of the calibration curve is verified on a regular basis. CCL, CCM, and CCH are the CCC standards at low, mid, and high concentration levels, respectively.

Internal Standards (IS) - are pure compounds with properties similar to the analytes of interest, which are added to field samples or extracts, calibration standards, and quality control standards at a known concentration. They are used to measure the relative responses of the analytes of interest and surrogates in the sample, calibration standard or quality control standard.

Laboratory Duplicate (LD) - is a field sample aliquot taken from the same sample container in the laboratory and analyzed separately using identical procedures. Analysis of laboratory duplicates provides a measure of the precision of the laboratory procedures.

Laboratory Fortified Blank (LFB) / Laboratory Control Sample (LCS) - is an aliquot of reagent water to which known concentrations of the analytes of interest are added. The LFB is analyzed exactly the same as the field samples. LFBs are used to determine whether the method is in control. FBL, FBM, and FBH are the LFB samples at low, mid, and high concentration levels, respectively.

Laboratory Method Blank (LMB) / Laboratory Reagent Blank (LRB) - is a sample of reagent water included in the sample batch analyzed in the same way as the associated field samples. The LMB is used to determine if method analytes or other background contamination have been introduced during the preparation or analytical procedure. The LMB is analyzed exactly the same as the field samples.

Laboratory Trip Blank (LTB) / Field Reagent Blank (FRB) - is a sample of laboratory reagent water placed in a sample container in the laboratory and treated as a field sample, including storage, preservation, and all analytical procedures. The FRB/LTB container follows the collection bottles to and from the collection site, but the FRB/LTB is not opened at any time during the trip. The FRB/LTB is primarily a travel blank used to verify that the samples were not contaminated during shipment.

Matrix Spike Duplicate Sample (MSD) / Laboratory Fortified Sample Matrix Duplicate (LFSMD) - is a sample aliquot taken from the same field sample source as the Matrix Spike Sample to which known quantities of the analytes of interest are added in the laboratory. The MSD is analyzed exactly the same as the field samples. Analysis of the MSD provides a measure of the precision of the laboratory procedures in a specific matrix. SDL, SDM, and SDH / LFSMDL, LFSMDM, and LFSMDH are the MSD or LFSMD at low, mid, and high concentration levels, respectively.

Matrix Spike Sample (MS) / Laboratory Fortified Sample Matrix (LFSM) - is a sample aliquot taken from field sample source to which known quantities of the analytes of interest are added in the laboratory. The MS is analyzed exactly the same as the field samples. The purpose is to demonstrate recovery of the analytes from a sample matrix to determine if the specific matrix contributes bias to the analytical results. MSL, MSM, and MSH / LFSML, LFSMM, and LFSMH are the MS or LFSM at low, mid, and high concentration levels, respectively.

Quality Control Standard (QCS) / Second Source Calibration Verification (SSCV) - is a solution containing known concentrations of the analytes of interest prepared from a source different from the source of the calibration standards. The solution is obtained from a second manufacturer or lot if the lot can be demonstrated by the manufacturer as prepared independently from other lots. The QCS sample is analyzed using the same procedures as field samples. The QCS is used as a check on the calibration standards used in the method on a routine basis.

Reporting Limit Check (RLC) / Initial Calibration Check Standard (ICCS) - is a procedural standard that is analyzed each day to evaluate instrument performance at or below the minimum reporting limit (MRL).

Surrogate Standard (SS) / Surrogate Analyte (SUR) - is a pure compound with properties similar to the analytes of interest, which is highly unlikely to be found in any field sample, that is added to the field samples, calibration standards, blanks and quality control standards before sample preparation. The SS is used to evaluate the efficiency of the sample preparation process.

Page 1 of 1

Page 5 of 7

Laboratory Report

Client:

Attn:

Report:

Priority:

Status:

PWS ID:


Ed Watson


419632

FL6290787

Standard Written

Final

Tampa, FL 33619


EEA ID #


CollectedBy:

ReceivedDate / Time

3964278 0787001 Lithia 544 06/18/18 13:11 Client 06/19/18 09:30

Sample Information

Report Summary

Method 544 analysis will be performed only if the associated Screening Microcystin by EPA 546 sample result is >=0.3 ug/L.




09/09/2018

Page 1 of 1

Page 6 of 7

laboratory report - hillsborough county, florida€¦ · 18/06/2018 · laboratory report this...

Documents